<DOC>
	<DOCNO>NCT00730314</DOCNO>
	<brief_summary>This clinical trial bone marrow transplantation patient diagnosis genetic disease blood cell HLA-matched sibling donor . Genetic disease blood cell include : Red blood cell defect e.g . hemoglobinopathy ( sickle cell disease thalassemia ) , Blackfan-Diamond anemia congenital chronic hemolytic anemia ; White blood cell defects/immune deficiency e.g . chronic granulomatous disease , Wiskott-Aldrich syndrome , Osteopetrosis , Kostmann 's syndrome ( congenital neutropenia ) , Hereditary Lymphohistiocytosis ( HLH ) ; Platelets defect e.g.Congenital amegakaryocytic thrombocytopenia ; Metabolic/storage disorder e.g . leukodystrophies , mucopolysaccharidoses Hurler disease ; Stem cell defect e.g.reticular agenesis , among many rare similar condition . The study treatment plan use new transplant treatment regimen aim try decrease acute toxicity complication associated standard treatment plan improve outcome The blood stem cell derive either unrelated donor unrelated umbilical cord blood .</brief_summary>
	<brief_title>Unrelated Hematopoietic Stem Cell Transplantation ( HSCT ) Genetic Diseases Blood Cells</brief_title>
	<detailed_description>This pilot clinical trial hematopoietic stem cell transplantation patient diagnosis genetic disease blood cell HLA-matched sibling donor . The stem cell derive 1 ) match unrelated donor ( MUD ) 2 ) unrelated umbilical cord blood ( UCB ) . Patients receive novel condition regimen Busulfan , Cytoxan Fludarabine ( Bu/Cy/Flu ) either Alemtuzumab ( Campath 1H ) recipient MUD rabbit Antithymocyte Globulin ( rATG ) recipient unrelated UCB prior hematopoietic stem cell transplant ( HSCT ) . It hypothesize reduce dosage Cytoxan decrease acute toxicity associate standard chemotherapy Busulfan Cytoxan ( i.e . sinusoidal obstructive syndrome ( SOS ) , hemorrhagic cystitis mucositis ) . And addition fludarabine condition regimen myeloablative dos Busulfan reduce dosage Cytoxan prior HSCT overcome engraftment barrier pose intact immune system , see patient genetic disease .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Granuloma</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Osteopetrosis</mesh_term>
	<mesh_term>Wiskott-Aldrich Syndrome</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<mesh_term>Chediak-Higashi Syndrome</mesh_term>
	<mesh_term>Fucosidosis</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<criteria>Lethal sublethal genetic disease blood cell , lack fully histocompatible sibling family donor Genetic disease would candidate protocol include show benefit allogeneic HSCT : Red blood cell defect , Leukocyte defects/ Primary immune deficiency , Platelets defect , Metabolic/storage disorder Stem cell defect . Renal : creatinine clearance glomerular filtration rate ( GFR ) ≥50 ml/min/1.73m2 require dialysis . Pulmonary : FEV1 , FVC DLCO ( correct hemoglobin ) ≥ 50 % predict . unable perform pulmonary function test , O2 saturation ≥ 92 % room air . Cardiac : Left ventricular ejection fraction rest must ≥ 40 % , shorten fraction ≥ 26 % Hepatic : Bilirubin ≤3x upper limit normal ( ULN ) ALT AST ≤ 5x age ( exception isolate hyperbilirubinemia due Gilbert 's syndrome ) . Patients 021 year age . Disease specific inclusion criterion ( applicable per protocol ) . Recipients general exclusion criterion , disease specific exclusion criterion applicable . Patient histocompatible sibling Endorgan failure precludes ability tolerate transplant procedure , include condition regimen . Creatinine clearance GFR &lt; 50 ml/min/1.73m2 renal failure require dialysis . Congenital heart disease result congestive heart failure . Severe residual CNS disease/impairment [ ( hemiplegia alone ) e.g . coma intractable seizure ] Ventilatory failure Major congenital anomaly adversely affect survival , e.g . CNS malformation Lansky score &lt; 40 % Karnofsky score &lt; 60 % HIV seropositivity Diagnosis Fanconi 's anemia , Severe Combined Immunodeficiency ( SCID ) Positive pregnancy test ( For female patient child bearing period ) Uncontrolled bacterial , viral , fungal infection ( currently take medication yet clinical symptom progress ) Disease specific exclusion criterion ( applicable per protocol ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>unrelated</keyword>
	<keyword>BMT</keyword>
	<keyword>HSCT</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>sickle cell disease</keyword>
	<keyword>thalassemia</keyword>
	<keyword>CGD</keyword>
	<keyword>HLH</keyword>
	<keyword>Blackfan-Diamond anemia</keyword>
	<keyword>Hurler</keyword>
	<keyword>leukodystrophy</keyword>
	<keyword>LAD I</keyword>
	<keyword>Genetic disease</keyword>
	<keyword>Red blood cell defect</keyword>
	<keyword>Leukocyte defect immune deficiency</keyword>
	<keyword>Hereditary Lymphohistiocytosis</keyword>
	<keyword>chronic granulomatous disease</keyword>
	<keyword>Wiskott-Aldrich syndrome</keyword>
	<keyword>Chediak Higashi syndrome</keyword>
	<keyword>CD40 ligand deficiency</keyword>
	<keyword>Hyper IgM syndrome</keyword>
	<keyword>leucocyte adhesion defect type 1</keyword>
	<keyword>Osteopetrosis</keyword>
	<keyword>congenital neutropenia</keyword>
	<keyword>X-linked lymphoproliferative disease</keyword>
	<keyword>Platelets defect</keyword>
	<keyword>Congenital amegakaryocytic thrombocytopenia</keyword>
	<keyword>Metabolic storage disorder</keyword>
	<keyword>Hurler disease</keyword>
	<keyword>leukodystrophies</keyword>
	<keyword>Niemann-Pick disease</keyword>
	<keyword>Fucosidosis</keyword>
	<keyword>Stem cell defect</keyword>
	<keyword>reticular agenesis</keyword>
</DOC>